MedTrace Logo

Deep Dive Randomized Control Trial

NCT00793260 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 174120

Last updated 2008-11-19

No results posted yet for this study

Summary

Compare two care management support program models on medical costs and utilization.

Conditions

Interventions

BEHAVIORAL

Enhanced Support

The Enhanced-Support Group program used lower risk thresholds for targeted outreach of individuals with chronic illness and for those likely to face discrete surgical interventions. Individuals at high financial risk but without one of the five chronic conditions were included in the Enhanced-Support Group. The Enhanced-Support Group received up to five initial reach attempts while the Usual-Support Group received up to three attempts. The Enhanced-Support Group used a 'tight loop' management structure including detailed, timely coach level feedback reports on efficiency and effectiveness.

BEHAVIORAL

Usual-Support

Predictive models in the Usual-Support Group were aimed at identifying individuals through medical claims and administrative data (such as hospitalization notification). The output of the predictive models is a rank-ordered, or stratified, list of individuals who have support needs. These lists were then used to generate outbound mail, interactive voice response (IVR) calls or calls by health coaches.

Sponsors & Collaborators

  • Health Net California

    collaborator UNKNOWN

  • Highmark Blue Cross Blue Shield

    collaborator UNKNOWN

  • Health Dialog

    lead INDUSTRY

Principal Investigators

  • David E Wennberg, MD, MPH · Health Dialog

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2007-06-30
Completion
2008-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00793260 on ClinicalTrials.gov